Current stock page

Catalysts

TWST Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

TWSTTwist Bioscience Corporation

Healthcare / Biotechnology

Low Priority

Above Peers

NeutralEdge 7/10
$111.60−$2.62 (−2.29%)

Latest quote

  • Momentum
    84
  • Value
    58
  • Quality
    59
  • Risk resilience
    32
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Jan 29, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 64/100

Momentum 84/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 40.60%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 84/100AIQ Edge 7/10 Above Peers
Beat rate
50%
4 of 8 reported periods
Average surprise
-2.8%
Across covered historical reports
Latest result
+17.3%
Nov 12, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 12, 2026—-$0.39-$0.32+17.3%$123.55M$126.64M
Aug 3, 2026—-$0.51-$0.56-10.6%$114.55M$118.4M
May 4, 2026—-$0.49-$0.71-44.9%$107.64M$110.72M
Feb 2, 2026—-$0.48-$0.50-4.2%$101.88M$103.7M
Nov 14, 2025—-$0.50-$0.45+10.0%$97.4M$99.01M
Aug 4, 2025—-$0.54-$0.47+13.0%$97.38M$96.06M
May 5, 2025—-$0.56-$0.66-17.9%$95.39M$92.79M
Feb 3, 2025—-$0.62-$0.53+14.5%$86.95M$88.71M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
9
Buy
3
Hold
1
Sell
12-month analyst target
$167.57
+50.15% versus current price
Based on 13 analyst observations. Targets are estimates, not predictions.
Low target
$125.00
+12.01% vs latest price
Average target
$167.57
+50.15% vs latest price
High target
$215.00
+92.65% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateJan 29, 2027

Next known earnings or reporting date.

EPS estimate-$0.38

Current analyst expectation for the upcoming report.

Revenue estimate$127.17M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score84

Where event reaction would show up first.

AIQ score64/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
13
Average target
$167.57
Target upside
50.15%
Target range
$125.00 - $215.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
gurufocus.com · Nov 12, 2026

Q4 2026 Twist Bioscience Corporation Earnings Call Transcript

Nov 12, 2026 / 01:00PM GMTOperator Good day, and thank you for standing by. Welcome to the Twist Bioscience fiscal 2026 fourth quarter financial results confere

insidermonkey.com · Nov 12, 2026

Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3

Artisan Partners, an investment management company, released its third-quarter 2026 investor letter for the “Artisan U.S. Small-Cap Growth Strategy”. The letter can be downloaded here.

seekingalpha.com · Sep 28, 2026

Twist Bioscience: Don't Confuse A Short Squeeze With An AI Revolution (NASDAQ:TWST)

Twist Bioscience (TWST) surged on multiple expansion and AI hype, not fundamentals; AI revenue looks limited and valuation rich.

finance.yahoo.com · Sep 22, 2026

Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership

Twist Bioscience Corporation (NASDAQ:TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug discovery ecosystem. On September 16, the company confirmed a strategic partnership with Lilly TuneLab, a platform created by Eli Lilly and Company (NYSE:LLY). As part of the strategic partnership, Twist will provide antibody characterization data […]

Open full news and sentiment

TWST Catalysts FAQ

What are the next catalysts for TWST stock?

TWST's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move TWST stock?

Upcoming events that could move TWST include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could TWST's next earnings report affect the stock?

TWST's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive TWST stock higher?

TWST could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt TWST stock?

TWST could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.